Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS-CoV-2 In Vitro
Go back to Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS-CoV-2 In Vitro(NASDAQ: MOLN) | Delayed: 6.86 -0.02 (0.29%) | |||||
---|---|---|---|---|---|---|
Previous Close | $6.88 | 52 Week High | $ | |||
Open | $7.27 | 52 Week Low | $ | |||
Day High | $7.27 | P/E | N/A | |||
Day Low | $6.72 | EPS | $ | |||
Volume | 82,146 |
(NASDAQ: MOLN) | Delayed: 6.86 -0.02 (0.29%) | |||||
---|---|---|---|---|---|---|
Previous Close | $6.88 | 52 Week High | $ | |||
Open | $7.27 | 52 Week Low | $ | |||
Day High | $7.27 | P/E | N/A | |||
Day Low | $6.72 | EPS | $ | |||
Volume | 82,146 |